These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY. BLIX S Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542 [No Abstract] [Full Text] [Related]
3. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
4. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
5. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA. ADAMIS DM; MANIATIS GM Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870 [No Abstract] [Full Text] [Related]
6. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
7. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
8. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS]. MATTIOLI G; RABITTI G; NAVA C Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219 [No Abstract] [Full Text] [Related]
9. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY. HAWKEY C; HOWELL M J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462 [TBL] [Abstract][Full Text] [Related]
10. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION. AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831 [No Abstract] [Full Text] [Related]
11. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD. BRAKMAN P; ASTRUP T Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193 [No Abstract] [Full Text] [Related]
12. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS. HELLE I; AAS K; GODAL HC Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607 [No Abstract] [Full Text] [Related]
13. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281 [No Abstract] [Full Text] [Related]
14. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen. HOPKINS TF; MEITES J Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684 [No Abstract] [Full Text] [Related]
15. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
16. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY]. SHIRAI T Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987 [No Abstract] [Full Text] [Related]